# VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI

> **NCT07533656** · — · ACTIVE_NOT_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 3600 (estimated)

## Conditions studied

- In-Stent Restenosis
- Coronary Artery Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07533656
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533656, "VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07533656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*